EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gut Microbiota‐Derived Propionate: A Potential Therapeutic Target for Diabetic Retinopathy via Regulating the Gut‐Retina Axis

Yishuo Gao, Ruizhe Wan, Hongxi Wu, Nanye Wang, Zhiping Chen, Wanxuan Chai, Zhipeng You, Kangcheng Liu iD

The FASEB Journal · 31.05.2026 · 40 (10)

DOI: 10.1096/fj.202600264r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 12.05.2026. Verfasst von Yishuo Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Propionates, Gastrointestinal Microbiome, Retina. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation, Science and Technology Research Project of Jiangxi Provincial Department of Education, Jiangxi Provincial Health Commission Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR), a prominent microvascular impairment arising from diabetes, causes substantial visual dysfunction. Emerging evidence indicates that intestinal dysbiosis promotes DR progression via the gut‐retina axis. Short‐chain fatty acids serve a critical function in regulating gut microbiota, and propionate, a vital member of them, has potential translational value in DR prevention and management through the gut‐retina axis. This review summarizes the impact of propionate on the retinal microenvironment by regulating gut microbiota and metabolites, focusing on its mechanisms influencing DR development, including modulating inflammation, protecting blood vessels, regulating immunity, exerting neuroprotection, and combating oxidative stress. It provides insights for devising propionate‐based therapeutic strategies against DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyPropionatesGastrointestinal MicrobiomeRetinaHumansAnimalsOxidative Stress

Stichwörter der Autor:innen

diabetic retinopathygut microbiotapropionateshort‐chain fatty acids“gut‐retina” axis

Substanzen

Propionates

Autor:innen und Institutionen

  • The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
  • Key Laboratory of Ophthalmology and Vision Sciences, Jiangxi Clinical Research Center for Ophthalmic Disease, Jiangxi Provincial Key Laboratory of Vitreoretinal Diseases for Health, Nanchang, Jiangxi Province, China.
  • Nanchang University Queen Mary School, Nanchang University, Nanchang, Jiangxi Province, China.

ORCID-Profile: Kangcheng Liu

Förderung

  • Jiangxi Provincial Natural Science Foundation
  • Science and Technology Research Project of Jiangxi Provincial Department of Education
  • Jiangxi Provincial Health Commission Science and Technology Plan Project
  • Natural Science Foundation of Jiangxi Province
  • Key Science and Technology Research Project in Jiangxi Province Department of Education

Zitieren

APA

Gao, Y., Wan, R., Wu, H., Wang, N., Chen, Z., Chai, W., You, Z., & Liu, K. (2026). Gut Microbiota‐Derived Propionate: A Potential Therapeutic Target for Diabetic Retinopathy via Regulating the Gut‐Retina Axis. The FASEB Journal, 40(10). https://doi.org/10.1096/fj.202600264r

Vancouver

Gao Y, Wan R, Wu H, Wang N, Chen Z, Chai W, et al. Gut Microbiota‐Derived Propionate: A Potential Therapeutic Target for Diabetic Retinopathy via Regulating the Gut‐Retina Axis. The FASEB Journal. 2026;40(10). doi:10.1096/fj.202600264r

BibTeX
@article{Gao2026,
  author = {Gao, Yishuo and Wan, Ruizhe and Wu, Hongxi and Wang, Nanye and Chen, Zhiping and Chai, Wanxuan and You, Zhipeng and Liu, Kangcheng},
  title = {Gut Microbiota‐Derived Propionate: A Potential Therapeutic Target for Diabetic Retinopathy via Regulating the Gut‐Retina Axis},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {10},
  doi = {10.1096/fj.202600264r}
}
Kostenlos starten →